Donna Mather
Family · San Diego, CANPI 1790243699
Payments from drug & device makers
Across 77 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$250
- Amgen$239
- AstraZeneca$206
- Bayer$129
- Novartis$113
- Dexcom, Inc.$102
- plus $493 from 17 others
What the payments were for
- Food & beverage$1,49498%
- Education$382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $250 |
| Amgen | 16 | $239 |
| AstraZeneca(2 entities) | 12 | $206 |
| Bayer | 5 | $129 |
| Novartis | 5 | $113 |
| Dexcom, Inc. | 5 | $102 |
| Xeris Pharmaceuticals, Inc. | 3 | $70 |
| Novo Nordisk | 3 | $64 |
| AbbVie | 2 | $52 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
| Travere Therapeutics, Inc. | 3 | $30 |
| Astellas Pharma US Inc | 1 | $30 |
| Pfizer | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $24 |
| Exact Sciences | 1 | $23 |
| GSK | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Merck | 1 | $16 |
| Abbott | 1 | $14 |
| Organon | 1 | $13 |
How this compares
$1,531 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $64,218 |
| JardianceEmpagliflozin | 30 | $35,439 |
| FarxigaDapagliflozin Propanediol | 19 | $17,929 |
| EliquisApixaban | 15 | $14,113 |
| KerendiaFinerenone | 18 | $12,359 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $11,199 |
| Repatha SureclickEvolocumab | 12 | $8,263 |
| TrulancePlecanatide | 11 | $6,037 |
| Atorvastatin Calcium | 262 | $4,841 |
| Levothyroxine Sodium | 106 | $1,673 |
| Losartan Potassium | 115 | $1,367 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,269 |
| Rosuvastatin Calcium | 59 | $1,228 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,154 |
| Metformin Hcl | 124 | $1,125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $64 | $64,21845 claims |
| Boehringer IngelheimJardiance | $25 | $35,43930 claims |
| AstraZenecaFarxiga | $206 | $17,92919 claims |
| PfizerEliquis | $26 | $14,11315 claims |
| BayerKerendia | $129 | $12,35918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.
Other family in San Diego
- Nancy GardettoSan Diego$394K
- Dawn MeyerSan Diego$270K
- Erin DwyerSan Diego$189K
- Lizaveta NikitsinaSan Diego$36K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Jennifer KangCerritos$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.